Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.51 |
| ▸ | PPARA | Q07869 | 5/20 | 0.51 |
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | TERT | O14746 | 3/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | PPARD | Q03181 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5452957 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL864034 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL2342147 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL3710792 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL11743976 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL14672999 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL347470 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL22555434 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL22555479 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL7902650 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1075 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036792-A | Preparation of diphenyl ether biphosphine ligand and application of diphenyl ether biphosphine ligand in carbonyl esterification reaction | 深圳职业技术大学 | 2026-05-15 | — | — | CN | claimed |
| US-12589377-B2 | Encapsulated composition comprising core-shell microcapsules and process for its preparation | GIVAUDAN SA (CH) | 2026-03-31 | — | — | US | claimed |
| EP-4695016-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-02-18 | — | — | EP | claimed |
| EP-4302747-B1 | SYSTEM FOR DISPENSING A COSMETIC PRODUCT | OREAL (FR) | 2026-01-14 | — | — | EP | claimed |
| EP-4655373-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2025-12-03 | — | — | EP | claimed |
| WO-2025202258-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2025-10-02 | — | — | WO | claimed |
| EP-3325588-B1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2025-04-16 | — | — | EP | claimed |
| US-12239209-B2 | System for dispensing a cosmetic product | L'OREAL (FR) | 2025-03-04 | — | — | US | claimed |
| WO-2024213536-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | claimed |
| WO-2024213507-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | claimed |
| US-20060205632-A1 | Pro-fragrance and pro-flavorant compositions | FLEXITRAL, INC. | 2006-09-14 | — | — | US | claimed |
| WO-2006085048-A2 | PRO-FRAGRANCE AND PRO-FLAVORANT COMPOSITIONS | FLEXITRAL, INC. (US) | 2006-08-17 | — | — | WO | claimed |
| US-6858575-B2 | Pro-perfume compositions and substrate-treating products and methods using them | PROCTER & GAMBLE COMPANY (US) | 2005-02-22 | — | — | US | claimed |
| EP-1448757-A1 | PRO-PERFUME COMPOSITIONS USED IN CLEANING OR FABRIC TREATMENT PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 2004-08-25 | — | — | EP | claimed |
| US-20030171250-A1 | Pro-perfume compositions and substrate-treating products and methods using them | THE PROCTER & GAMBLE COMPANY | 2003-09-11 | — | — | US | claimed |
| WO-2003046118-A1 | PRO-PERFUME COMPOSITIONS USED IN CLEANING OR FABRIC TREATMENT PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 2003-06-05 | — | — | WO | claimed |
| EP-1314777-A1 | Pro-perfume compositions used in cleaning or fabric treatment products | THE PROCTER & GAMBLE COMPANY (US) | 2003-05-28 | — | — | EP | claimed |
| CN-1361817-A | Perfume compositions | PROCTER & GAMBLE (US) | 2002-07-31 | — | — | CN | claimed |
| EP-1072673-A2 | Perfume compositions | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-31 | — | — | EP | claimed |
| WO-2001005919-A2 | PERFUME COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12589377-B2 | Encapsulated composition comprising core-shell microcapsules and process for its preparation | CUTA, EXOC1, EXOSC10 | PPARG 3841/4885PPARA 4555/4885CNR1 2945/4885 |
| US-12239209-B2 | System for dispensing a cosmetic product | PDE12, SAMM50, POLR1C | PPARG 177/4885PPARA 476/4885CNR1 2908/4885 |
| US-20030171250-A1 | Pro-perfume compositions and substrate-treating products and methods using them | FASN, ALOX5, PAM | PPARG 749/4885PPARA 284/4885CNR1 3046/4885 |
| US-20060205632-A1 | Pro-fragrance and pro-flavorant compositions | TAS2R10, TAS2R9, OR10J3 | PPARG 500/4885PPARA 587/4885CNR1 562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.